Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cerebellum (London, England)|June 22, 2012
Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1Nupur Nag, Volga Tarlac, Elsdon StoreyInternational Journal of Molecular Sciences|November 14, 2019
Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?Simeng Li, Volga Tarlac, Justin R HamiltonJournal of Neuroscience Methods|March 23, 2010
Expression and purification of ataxin-1 proteinRhonda Husain-Ponnampalam, Victor Turnbull, Volga Tarlac, et al.Protein Expression and Purification|September 7, 2011
Reprint of: Expression and purification of ataxin-1 proteinRhonda Husain-Ponnampalam, Victor Turnbull, Volga Tarlac, et al.Journal of Thrombosis and Haemostasis : JTH|October 12, 2023
PI3KC2α inhibition is antithrombotic in blood from hypercholesterolemic miceNatasha M Setiabakti, Volga Tarlac, Pia Larsson, et al.Cerebellum & Ataxias|September 3, 2015
Coeliac disease patients do not produce antibodies to a common cerebellar epitopeVolga Tarlac, Louise Kelly, Robert P Anderson, et al.The International Journal of Neuroscience|July 27, 2007
Inclusion formation by ataxins -1, -2, -3, and -7Volga Tarlac, Victor Turnbull, Daniela Stefani, et al.Platelets|August 22, 2020
Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902Simeng Li, Volga Tarlac, Roberto B I Christanto, et al.Cerebellum (London, England)|October 23, 2012
HLA-DR3-DQ2 mice do not develop ataxia in the presence of high titre anti-gliadin antibodiesVolga Tarlac, Louise Kelly, Nupur Nag, et al.Brain Research|October 21, 2004
Different ataxin-2 antibodies display different immunoreactive profilesVictor J Turnbull, Elsdon Storey, Volga Tarlac, et al.Pageof 2